SNORA27: A Non-Coding RNA Molecule with Potential as A Drug Target Or Biomarker

Target Name: SNORA27

NCBI ID: G619499

SNORA27

Other Name(s): Small nucleolar RNA, H/ACA box 27 | ACA27 | small nucleolar RNA, H/ACA box 27

SNORA27: A Non-Coding RNA Molecule with Potential as A Drug Target Or Biomarker

SNORA27, also known as Small Nucleolar RNA (snRNA), is a non-coding RNA molecule that is found in the nucleolus of eukaryotic cells. It plays a crucial role in the regulation of gene expression, DNA replication, and other cellular processes. SNORA27 is coded in the H/ACA box 27 gene, which is located on chromosome 9p36.

The H/ACA box is a region of the gene that contains a specific DNA-binding motif. This motif is responsible for the binding of various proteins to the H/ACA box, which in turn can modulate gene expression. The H/ACA box is a widely conserved region that is found in many different organisms, including humans.

SNORA27 is a non-coding RNA molecule that is highly conserved in its structure and sequence compared to other non-coding RNAs. It has a length of approximately 24 amino acids and a calculated melting temperature of 59.5 degrees Celsius. SNORA27 is predominantly expressed in the nucleolus, where it is involved in the regulation of gene expression and DNA replication.

SNORA27 has been shown to play a role in the regulation of gene expression in various organisms, including humans. For example, studies have shown that SNORA27 can repress the expression of certain genes in the nucleus of human cells, such as the gene encoding the protein known as heat shock protein (HSP70). This suggests that SNORA27 may be a potential drug target or biomarker for the treatment of certain diseases.

Another example is the regulation of DNA replication. SNORA27 has been shown to play a role in the regulation of the DNA replication process in various organisms. For instance, studies have shown that SNORA27 can interact with the protein known as DnaC, which is involved in the regulation of DNA replication. This interaction between SNORA27 and DnaC suggests that SNORA27 may be a potential drug target or biomarker for the treatment of certain cancers.

In addition to its role in gene expression and DNA replication, SNORA27 has also been shown to play a role in the regulation of cellular processes other than gene expression and DNA replication. For example, studies have shown that SNORA27 can interact with the protein known as TRF2, which is involved in the regulation of cellular processes such as cell growth and differentiation. This interaction between SNORA27 and TRF2 suggests that SNORA27 may be a potential drug target or biomarker for the treatment of certain diseases associated with cellular processes.

Despite the potential implications of SNORA27 as a drug target or biomarker, more research is needed to fully understand its role in the regulation of gene expression and cellular processes. In the future, researchers may use various techniques, such as RNA sequencing and biochemical assays, to study the function of SNORA27 in greater detail.

In conclusion, SNORA27 is a non-coding RNA molecule that is found in the nucleolus of eukaryotic cells. It has been shown to play a role in the regulation of gene expression, DNA replication, and other cellular processes. SNORA27 is coded in the H/ACA box 27 gene and is a potential drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand the function of SNORA27 and its potential as a drug.

Protein Name: Small Nucleolar RNA, H/ACA Box 27

The "SNORA27 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA27 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets